Cell Pathways explores SAANDs as new class of anticancer drugs; patent issues in U.S. Jan. 19, 1999 No Comments
Dose of O6-benzylguanine for use with BCNU in brain cancer patients determined Jan. 19, 1999 No Comments
Relationship between antitumor activity of bombesin/GRP antagonists and effects on EGF receptors Jan. 19, 1999 No Comments
Cancer Research Campaign Technology evaluates new antitumor trimelamol analogues Jan. 19, 1999 No Comments
Antitumor candidate originating in Kazakstan slated for development in U.S. and other countries Jan. 18, 1999 No Comments
Greater antitumor efficacy and less toxicity obtained with liposomal cisplatin Jan. 18, 1999 No Comments
Onyx expands ONYX-015 clinical trials in liver metastases of colorectal cancer Jan. 15, 1999 No Comments